Mono Pharmacare Limited (NSE:MONOPHARMA)
India flag India · Delayed Price · Currency is INR
8.95
0.00 (0.00%)
Sep 10, 2026, 3:19 PM IST

Mono Pharmacare Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,6571,6571,6841,224331.44370.93
Revenue Growth
12.30%-1.62%37.65%269.19%-10.65%30.71%
Gross Profit
88.6788.67160.72116.7539.0223.63
Operating Income
38.9438.9476.7662.8322.4812.84
Net Income
3.533.5330.924.429.443.51
Earnings Per Share
0.200.201.751.591.670.71
EPS Growth
-54.02%-88.56%10.00%-4.55%134.45%274.94%

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
9.849.846.983.634.182.45
Total Debt
565.02565.02535.6414.4399.2764.39
Net Cash (Debt)
-555.18-555.18-528.63-410.78-395.09-61.95
Net Cash Growth
------
Net Cash Per Share
-31.47-31.47-29.92-26.76-69.75-12.60

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
22.9722.97-43.03-87.72-395.42.4
Capital Expenditures
-0.05-0.05-2.26-1.75-6.33-0.14
Free Cash Flow
22.9222.92-45.29-89.47-401.732.26
Free Cash Flow Growth
290.81%-----

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
5.35%5.35%9.54%9.54%11.77%6.37%
Operating Margin
2.35%2.35%4.56%5.13%6.78%3.46%
Pretax Margin
0.35%0.35%2.65%2.64%3.98%1.49%
Profit Margin
0.21%0.21%1.84%2.00%2.85%0.95%
FCF Margin
1.38%1.38%-2.69%-7.31%-121.21%0.61%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
44.7555.8413.2131.90--
P/FCF Ratio
6.908.60----
PS Ratio
0.100.120.240.64--